Table 1 Patient and catheter characteristics
Patient characteristics | Patients, n = 12 (100%) |
Gender; female, number | 7 (58%) |
Age (years), median (interquartile range) | 70 (63–76) |
BMI, median (interquartile range) | 26 (22–28) |
Length of hospital stay (days), median (interquartile range) | 8.5 (4.5–24) |
Comorbidities, number | |
Cardiovascular disease | 9 (75%) |
Diagnosed or suspected malignancy | 7 (58%) |
Hypertension | 5 (42%) |
Hyperlipidaemia | 5 (42%) |
Lung disease (COPD, asbestosis) | 4 (33%) |
Smoking | 4 (33%) |
Diabetes | 3 (25%) |
Cerebrovascular disease | 3 (25%) |
Kidney failure (with or without dialysis) | 2 (17%) |
Alcoholism | 2 (17%) |
Psychiatric disorders (depression, anxiety) | 2 (17%) |
Heart failure | 1 (8.0%) |
Organ transplantation (kidney and pancreas) | 1 (8.0%) |
Obesity | 1 (8.0%) |
Previous deep venous thrombosis or pulmonary embolism | 0 (0.0%) |
Cause of death, number | |
Acute myocardial infarction | 3 (25%) |
Pneumonia and/or acute respiratory distress syndrome | 3 (25%) |
Hypovolaemic shock | 2 (17%) |
Multiorgan failure | 1 (8.0%) |
Heart failure | 1 (8.0%) |
Septic shock | 1 (8.0%) |
Intracranial haemorrhage | 1 (8.0%) |
Patients with another CICC within one year before death, number | 0 (0.0%) |
Patients with prophylactic enoxaparin, number | 11 (92%) |
Patients with 75 mg acetylsalicylic acid daily | 2 (17%) |
Routine coagulation during length of stay, median (interquartile range) | |
Platelet count (× 109/L) | 269 (146–301) |
Prothrombine time, INR | 1.2 (1.0–1.4) |
Acute partial thromboplastin time (s) (normal range 26–33 s) | 29 (27–34) |
Fibrinogen (g/L), n = 10 | 2.8 (1.8–5.4) |
Catheter characteristics | Catheters, n = 13 (100%)a |
Type of catheter, number | |
Non-coated polyurethane central venous catheterb | 12 (92%) |
Silicone central haemodialysis catheterc | 1 (8.0%) |
Catheter length, number | |
15 cm | 8 (62%) |
20 cm | 5 (38%) |
Number of catheter lumen, number | |
1 (5 French) | 1 (8.0%) |
2 (7 and 13.5d French) | 3 (23%) |
3 (7 French) | 2 (15%) |
5 (9.5 French) | 7 (54%) |
Insertion site, number | |
Internal jugular vein | 12 (92%) |
Subclavian vein | 1 (8.0%) |
Insertion side; right, number | 10 (77%) |
Number of skin punctures, number | 1 [1] |
Real time ultrasound guided insertion, number | 12 (92%) |
Insertion complications, number | 0 (0.0%) |
Days with catheter, median (interquartile range) | 7 (1.8–20) |